§Why CasetextPricing

National Institute of Allergy and Infectious Diseases; Notice of Closed Meetings

89 Fed. Reg. 77165 (Sep. 20, 2024)

National Institute of Allergy and Infectious Diseases; Notice of Closed Meetings

Download PDF
Federal RegisterSep 20, 2024
89 Fed. Reg. 77165 (Sep. 20, 2024)
Document Headings

Document headings vary by document type but may contain the following:

  • the agency or agencies that issued and signed a document
  • the number of the CFR title and the number of each part the document amends, proposes to amend, or is directly related to
  • the agency docket number / agency internal file number
  • the RIN which identifies each regulatory action listed in the Unified Agenda of Federal Regulatory and Deregulatory Actions

    • See the Document Drafting Handbook for more details.

    Department of Health and Human Services National Institutes of Health

    Pursuant to section 1009 of the Federal Advisory Committee Act, as amended, notice is hereby given of the following meetings.

    The meetings will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy.

    Name of Committee: National Institute of Allergy and Infectious Diseases Special Emphasis Panel; NIAID Investigator Initiated Program Project Applications (P01 Clinical Trial Not Allowed).

    Date: October 18, 2024.

    Time: 10:00 a.m. to 5:00 p.m.

    Agenda: To review and evaluate grant applications.

    Place: National Institute of Allergy and Infectious Diseases, National Institutes of Health, 5601 Fishers Lane, Rockville, MD 20892 (Video Assisted Meeting).

    Contact Person: Stephen A. Gallo, Ph.D., Scientific Review Officer, Scientific Review Program, 5601 Fishers Lane, MSC 9834, Rockville, MD 20892, (240) 669-2858, steve.gallo@nih.gov.

    Name of Committee: National Institute of Allergy and Infectious Diseases Special Emphasis Panel; NIAID Investigator Initiated Program Project Applications (P01 Clinical Trial Not Allowed).

    Date: October 22, 2024.

    Time: 10:00 a.m. to 5:00 p.m.

    Agenda: To review and evaluate grant applications.

    Place: National Institute of Allergy and Infectious Diseases, National Institutes of Health, 5601 Fishers Lane, Rockville, MD 20892 (Video Assisted Meeting).

    Contact Person: Stephen A. Gallo, Ph.D., Scientific Review Officer, Scientific Review Program, 5601 Fishers Lane, MSC 9834, Rockville, MD 20892, (240) 669-2858, steve.gallo@nih.gov.

    (Catalogue of Federal Domestic Assistance Program Nos. 93.855, Allergy, Immunology, and Transplantation Research; 93.856, Microbiology and Infectious Diseases Research, National Institutes of Health, HHS)

    Dated: September 16, 2024.

    Lauren A. Fleck,

    Program Analyst, Office of Federal Advisory Committee Policy.

    [FR Doc. 2024-21505 Filed 9-19-24; 8:45 am]

    BILLING CODE 4140-01-P